ADAOBI EZEANOLUE: Open Payments
NPI 1275988115 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 14 payments from 7 companies in 2025. Trend: 2023 $827 · 2024 $330 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $165 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Vanda Pharmaceuticals Inc. | 2 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Amgen Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
Products named: QULIPTA, FANAPT, REXULTI, Kerendia, OTEZLA, ABILIFY ASIMTUFII, Rybelsus, VRAYLAR.
Industry payments across NV — which companies pay providers there.
